Sachs on TwitterFollow us on Twitter @SachsAssociates
sachs associates   3rd ANNUAL
Sachs Cancer Bio Partnering &
Investment Forum

Promoting Public & Private Sector Collaboration & Investment
in Drug Development
    23rd February 2015 • New York Academy of Sciences • USA
Register Now
To Exhibit
sachs sachs sachs sachs sachs sachs sachs
Biotech i Europe Investor Forum
sachs sachs



The 3rd Annual Sachs Cancer Bio Partnering & Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering and funding/investment. We expect around 200 delegates and there is an online meeting system and meeting facilities to make the event transactional. There will also be a track of about 30 presentations by listed and private biotechnology companies seeking licensing/investment.


The 3rd Annual Sachs Cancer Bio Partnering & Investment Forum
will cover keynote speeches and panels on:

  • Deal Making
  • Gene & Cell Therapy
  • Investment
  • Next Gen Immunotherapeutics
  • Personalized Medicine & Diagnostics
  • Public & Private Partnerships
    Opening Speech:
    The Promise and Threat of Precision Cancer Medicine

    Barrett J. Rollins, MD, PhD,
    Linde Family Professor of Medicine, Harvard Medical School
    Chief Scientific Officer, Dana-Farber Cancer Institute

    Deal Making
    Co-chaired by:
    Anne Altmeyer, VP, Business Development, Head Negotiation, Oncology,
    Novartis Pharmaceuticals
    Dov Hass, Associate, Morgan. Lewis & Bockius LLP
    Catherine Pickering, Head of Oncology Licensing, Global BD, Merck Serono SA
    Dennis Purcell, Senior Managing Partner, Aisling Capital
    Francis Kern, Senior Director of External Scientific Affairs, Daiichi Sankyo Inc.
    Howard J. Fingert, Senior Medical Director, Business Development & Clinical Intelligence,
    Takeda Oncology
    Ji Li, Vice President, Business Development and Licensing, Merck & Co., Inc.
    John Gustofson, Senior Director, Venture and Early Stage Collaboration, AbbVie
    Steven Tregay, Chief Executive Officer, Forma Therapeutics

    Next Gen Immunotherapeutics
    Co-chaired by:
    Mara Goldstein, Managing Director & Senior Biotechnology Analyst, Cantor Fitzgerald
    Raffaele Baffa, Senior Director, Translational and Experimental Medicine, Sanofi Aventis SA
    Gil Beyen, Chairman and CEO, Erytech Pharma
    Greg Naeve, Head of Strategic Research Partnerships, Oncology, Pfizer
    Jeff Abbey, President & CEO, Argos Therapeutics, Inc.
    Marc Mansour, CEO, Immunovaccine Inc.
    Paul Higham, Managing Director, immatics biotechnologies GmbH
    Robert Petit, CSO, Advaxis Inc.

    Gene & Cell Therapy
    Co-chaired by:
    Maxim Jacobs, Senior Healthcare Analyst, Edison Group
    Mike Rice, Senior Consultant, Defined Health
    Mike Khan, CMO, Silence Therapeutics
    Robert O. Dillman, Vice-President of Oncology, NeoStem, Inc.
    Peshwa Madhusudan, Executive Vice President, Cellular Therapies, MaxCyte, Inc.
    Peter Hoang, Senior Vice President Business Development & Strategy, Bellicum Pharmaceuticals, Inc.

    Personalised Medicine & Diagnostiics
    Co-chaired by:
    Rowan Chapman, Managing Director, Ventures, GE Healthcare
    Stephan Brozak, Managing Partner and President, WBB Securities, LLC
    Bernhard Sixt, President and CEO, ImmunID
    Claudio Carini, Global Head of Immunology & Biomarkers, Pfizer
    Lisa Ricciardi, SVP Corporate & Business Development, Foundation Medicine
    Thomas H. Tulip, President and Chief Business Officer, Navidea Biopharmaceuticals

    Investment Roundtable
    Co-chaired by:
    Beth Jacobs, Managing Partner, Excellentia Global Partners
    Stuart Barich, Managing Director, Raymond James Financial, Inc.
    Daniel Teper, CEO, Immune Pharmaceuticals Inc.
    Jens Eckstein, President, S.R.One Limited
    John DeYoung, Vice President, Worldwide Business Development, Pfizer
    Philippe Mauberna, CFO, Nanobotix
    Shakti Narayan, Sr. Director, Transactions, Johnson & Johnson Innovation Center
    Todd Foley, Managing Director, MPM Capital

    Public & Private Partnerships
    Co-chaired by:
    Lee Greenberger, Chief Scientific Officer, The Leukemia and Lymphoma Society
    O. Prem Das, Chief Business Development Officer, Dana-Farber Cancer Institute
    Daniel Auclair, Vice President, Translational Research, The Multiple Myeloma Research Foundation
    Darryl Mitteldorf, Executive Director, Global Prostate Cancer Alliance
    Juan Carlos Lopez, Head of Academic Relations & Collaborations, Roche
    Leigh Zawel, Site Head, New York and Boston Centers for Therapeutic Innovation, Pfizer
    Louise Perkins, Chief Science Officer, Melanoma Research Alliance
    Steven Young, President and COO, Addario Lung Cancer Medical Institute

    For full list of 2015 participating speakers click HERE

    Review the full list of 2014 Forum Speakers & Chairs >>


Presenting Opportunities for Biotech, Pharmaceutical companies  and Patient Advocacy Groups

Presenting at the forum offers excellent opportunities to showcase activities and highlight investment and partnership opportunities. Biotech companies will be able to communicate investment and licensing opportunities. These are for both public and private companies. The audience is comprised of financial and industry investors. These are streamed 10 or 15 minute presentations.

Sachs forums are recognised as the leading international stage for those interested in investing in the biotech and life science industry and are highly transactional. They draw together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. The New York forum provides the additional interaction with the academic/scientific and patient advocacy communities.

Sponsorship and Exhibition

Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.

Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.

To learn more about presenting, exhibition or sponsorship opportunities, please contact
Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia.

Conference Guide:
Click the cover below to download the full conference guide.
Sachs - 3rd Annual Sachs Cancer Bio

Login in NOW – add your profile directly to the system and start booking your meetings.

Special Sachs Associates Forum Rates
To learn more about presenting, exhibition or sponsorship opportunities, please contact Silvia Kar
+ 44 (0)203 463 4890 or by email: Silvia Kar.
  3rd Annual Sponsors and Supporters